Back to Search Start Over

DECTIN-1: A modifier protein in CTLA-4 haploinsufficiency.

Authors :
Turnbull C
Bones J
Stanley M
Medhavy A
Wang H
Lorenzo AMD
Cappello J
Shanmuganandam S
Pandey A
Seneviratne S
Brown GJ
Meng X
Fulcher D
Burgio G
Man SM
de Lucas Collantes C
Gasior M
López Granados E
Martin P
Jiang SH
Cook MC
Ellyard JI
Athanasopoulos V
Corry B
Canete PF
Vinuesa CG
Source :
Science advances [Sci Adv] 2023 Dec 08; Vol. 9 (49), pp. eadi9566. Date of Electronic Publication: 2023 Dec 06.
Publication Year :
2023

Abstract

Autosomal dominant loss-of-function (LoF) variants in cytotoxic T-lymphocyte associated protein 4 ( CTLA4 ) cause immune dysregulation with autoimmunity, immunodeficiency and lymphoproliferation (IDAIL). Incomplete penetrance and variable expressivity are characteristic of IDAIL caused by CTLA-4 haploinsufficiency (CTLA-4h), pointing to a role for genetic modifiers. Here, we describe an IDAIL proband carrying a maternally inherited pathogenic CTLA4 variant and a paternally inherited rare LoF missense variant in CLEC7A, which encodes for the β-glucan pattern recognition receptor DECTIN-1. The CLEC7A variant led to a loss of DECTIN-1 dimerization and surface expression. Notably, DECTIN-1 stimulation promoted human and mouse regulatory T cell (T <subscript>reg</subscript> ) differentiation from naïve αβ and γδ T cells, even in the absence of transforming growth factor-β. Consistent with DECTIN-1's T <subscript>reg</subscript> -boosting ability, partial DECTIN-1 deficiency exacerbated the T <subscript>reg</subscript> defect conferred by CTL4-4h. DECTIN-1/ CLEC7A emerges as a modifier gene in CTLA-4h, increasing expressivity of CTLA4 variants and acting in functional epistasis with CTLA-4 to maintain immune homeostasis and tolerance.

Details

Language :
English
ISSN :
2375-2548
Volume :
9
Issue :
49
Database :
MEDLINE
Journal :
Science advances
Publication Type :
Academic Journal
Accession number :
38055819
Full Text :
https://doi.org/10.1126/sciadv.adi9566